IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management III, LLC

Q3 2016 Holdings

Filed 2016-11-14 | 17 holdings | $214.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$64.1K1,697,88429.9%
Alder BioPharmaceuticals, Inc.(ALDR1EUR)COM014339105$52.0K1,585,68324.3%
Wave Life Sciences Ltd.(WVE)SHSY95308105$23.6K727,49611.0%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$14.0K935,0206.6%
Intellia Therapeutics, Inc.(NTLA)COM45826J105$13.0K763,6886.1%
Global Blood Therapeutics, Inc.COM37890U108$10.5K455,5904.9%
NanoString Technologies, Inc.(NSTGEUR)COM63009R109$9.7K485,6004.5%
Momenta Pharmaceuticals, Inc.(MNTA)COM60877T100$7.0K595,5133.3%
Protagonist Therapeutics, Inc.(PTGX)COM74366E102$6.3K346,2812.9%
Epizyme, Inc.(EPZMEUR)COM29428V104$6.0K611,7772.8%
Zafgen, Inc.COM98885E103$1.8K537,4950.8%
Akari Therapeutics, PLCSPONSORED ADR00972G108$1.7K197,0720.8%
Lipocine Inc.COM53630X104$1.4K302,6400.6%
Audentes Therapeutics, Inc.(BOLDEUR)COM05070R104$1.2K66,5530.6%
Orexigen Therapeutics, Inc.COM686164104$844254,2570.4%
Syros Pharmaceuticals, Inc.COM87184Q107$83260,0000.4%
BioDelivery Sciences International, Inc.(BDSIUSD)COM09060J106$12747,1580.1%